Viewing Study NCT05084027


Ignite Creation Date: 2025-12-25 @ 5:07 AM
Ignite Modification Date: 2026-02-01 @ 3:07 PM
Study NCT ID: NCT05084027
Status: UNKNOWN
Last Update Posted: 2021-10-27
First Post: 2021-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Malignancy View
None Older Patients View
None Allogeneic Hematopoietic Stem Cell Transplantation View
Keywords: